Business as a regulatory leader for risk governance? The compact initiative for liability and redress under the Cartagena Protocol on Biosafety

Bibliographic Data

ID4329757
AuthorsAmandine Orsini (0000-0002-1453-9707, Université Libre de Bruxelles, corresponding author)
Year2012
Volume21
Issue6
Pages960-979
Publication date2012-11-01
Open AccessNo
TypeARTICLE
VenueEnvironmental Politics (JOURNAL)
Journal identifiersISSN: 0964-4016 • E-ISSN: 1743-8934
PublisherInforma UK Limited (PUBLISHER • GB)
DOI10.1080/09644016.2012.717375
OpenAlexW2060854030
LanguageEN
Citations received2
References cited18

In March 2008, the six world leading agro-biotechnology companies, presented a private, international instrument for liability and redress to cover the environmental damage caused by genetically modified organisms. The proposal was rejected by governments, who instead adopted a binding supplementary liability and redress protocol to the Cartagena Protocol on Biosafety, with no content transfer from the business initiative. Elaborating on this case study, it is explained how powerful business proposals can turn into a policy failure. Business conflicts are identified as one major explanatory factor. The fragmentation of business interests and the lack of business support for the six major firms’ initiative have discredited the role of corporations as regulatory leaders. Business unity is found to be a decisive, necessary condition for the endorsement of corporate proposals by policymakers

Biosafety · Business · Business risks · Corporate governance · Economics · International business · Liability · Limited liability · Management · Political science · Redress · Biotechnology and Related Fields · CRISPR and Genetic Engineering · Genetically Modified Organisms Research · Law · Accounting · Biotechnology · Finance

Tools

Open DOISci-HubOpen Access